Clinical Trial Update: FDA Approved Medication to Reduce Binge Eating and/or Purging [Phase 1]

View source ↗

Summary

Phase 1 trial update noting the completion of a study evaluating an FDA-approved medication to reduce binge eating and/or purging. The study enrolled participan…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Binge Eating Disorder
• Bulimia Nervosa

Snippet

Sponsor: Stanford University | Conditions: Binge Eating Disorder, Bulimia Nervosa | Phase 1 | Status: COMPLETED